Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era

Journal of the Pediatric Infectious Diseases Society
Liset OlarteSheldon L Kaplan

Abstract

We identified 53 infants aged 0-60 days with invasive pneumococcal disease (IPD) at 8 children's hospitals in the United States (2005-2015). After the introduction of 13-valent pneumococcal conjugate vaccine (PCV13), IPD caused by PCV13 serotypes decreased ~30% providing some evidence of indirect protection. However, approximately 60% of IPD was still caused by PCV13 serotypes.

References

Nov 5, 2003·Pediatrics·Jill A HoffmanSheldon L Kaplan
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Katherine A PoehlingWilliam Schaffner
Aug 26, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Anthony G ScottDavid Goldblatt
Apr 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Caroline C TigoiJ Anthony G Scott
Nov 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shamez N LadhaniElizabeth Miller
May 15, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Liset OlarteSheldon L Kaplan
Dec 13, 2016·Pediatrics·Stephanie J SchragRuth Lynfield
Feb 16, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Liset OlarteSheldon L Kaplan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.